申请人:ABBOTT LAB
公开号:WO2012083170A1
公开(公告)日:2012-06-21
Compounds effective in inhibiting replication of Hepatitis C virus ("HCV") are described. This invention also relates to processes of making such compounds, compositions comprising such compounds, and methods of using such compounds to treat HCV infection.
描述了一种有效抑制丙型肝炎病毒(“HCV”)复制的化合物。本发明还涉及制备此类化合物的方法、含有此类化合物的组合物,以及使用此类化合物治疗HCV感染的方法。